CN Stock MarketDetailed Quotes

688336 Sunshine Guojian Pharmaceutical

Watchlist
  • 24.38
  • +0.63+2.65%
Noon Break Nov 4 11:29 CST
15.04BMarket Cap41.32P/E (TTM)

Sunshine Guojian Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sunshine Guojian Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 23, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
342.78M
--
+35.60%
Net Income
--
98.39M
--
+49.66%
Analyst Rating
Strong Buy

Nov 3, 2024

Sunshine Guojian Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.350B--
--2024/FY-- / 1.272B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.350B--
--2024/FY-- / 1.272B--
Mar 21, 20242023/FY1.014B / 959.690M--
Mar 22, 20232022/FY825.492M / 969.620M--
Mar 29, 20222021/FY928.807M / 1.147B--

Unlock Free Earnings Estimates

Sunshine Guojian Pharmaceutical Earnings Reports

  • Sansei Guojian: Third Quarter Report 2024

    Oct 22 12:00 ET

  • Sunshine Guojian Pharmaceutical: Half-year report for the year 2024.

    Aug 22 12:00 ET

  • Sunshine Guojian Pharmaceutical: Summary of Half-Year Report in 2024.

    Aug 22 12:00 ET

  • Sansei Guojian: Report for the first quarter of 2024

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data